Introduction
Hemophilia is a rare inherited bleeding disorder that affects the body’s ability to form blood clots properly. People living with hemophilia A or hemophilia B have low or missing clotting factors needed for normal blood clotting, which can increase the risk of prolonged bleeding episodes and spontaneous internal bleeding.
For many individuals with hemophilia, ongoing preventive treatment is an important part of reducing bleeding complications and protecting long-term health. Repeated bleeding episodes, especially into joints and muscles, may lead to chronic pain, joint damage, mobility limitations, and reduced quality of life over time.
Alhemo is a monoclonal antibody therapy designed to help prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or hemophilia B, including individuals with clotting factor inhibitors. The medication works differently from traditional factor replacement therapies by targeting tissue factor pathway inhibitor, also known as TFPI, to help improve clotting activity.
Unlike many traditional hemophilia treatments that require intravenous infusions, Alhemo is administered as a once-daily subcutaneous injection using a prefilled pen device.
Although advances in hemophilia treatment may improve bleed prevention and long-term disease management, specialty biologic medications often come with substantial treatment costs. Specialty pharmacy coordination, ongoing monitoring, insurance authorization requirements, and long-term therapy expenses may create significant financial challenges for patients and families.
Prescription Hope helps individuals explore medication access, support, and patient assistance programs for eligible prescription medications. Our advocates work on behalf of patients to help simplify enrollment coordination, gather required documentation, coordinate signatures, and communicate with manufacturers.
After approval, Prescription Hope continues to manage the patient’s medication access, offering refill scheduling, document updates, yearly renewals, and more.
Through Prescription Hope’s medication access service, patients and families receive guidance and assistance while navigating medication affordability concerns associated with specialty hemophilia therapies like Alhemo.
What Is the Alhemo Patient Assistance Program?
Those with hemophilia often require expensive medications to help treat their condition. Much like other conditions, the medications available can retail for more than the average American can afford out of pocket.
Because of this, pharmaceutical manufacturers have designed a solution. Many times, manufacturers of brand-name medications will also launch Patient Assistance Programs. These provide brand-name medication to qualified patients at affordable rates, often at low or no cost.
Considering patients may not be able to afford Alhemo’s price or find affordable Alhemo, a hemophilia medication assistance program can be just the answer.
However, there is often a catch. Patient assistance programs are notorious for being complex and difficult to apply for. Patients attempting to apply have become frustrated and overwhelmed with the process, eventually giving up or being rejected due to a mistake or missed deadline.
But there is a solution.
How Expert Advocates Help Make Alhemo More Affordable
Professional Application Management
When a patient is looking for affordable medication access and finds a patient assistance program, they may benefit by partnering with someone who is an expert in the field.
Prescription Hope’s team of patient advocates comes alongside patients every day to help them apply for their intended patient assistance program.
Our patient advocates not only fill out all application forms for you, but they also collect all necessary documents, coordinate with healthcare providers to secure vital signatures, communicate with manufacturers, and navigate the complex patient assistance program landscape on your behalf.
Predictable Monthly Pricing
When a patient’s insurance coverage is inadequate, they can often feel helpless while staring at hundreds or thousands of dollars per month in medication costs.
Thankfully, plenty of savings options exist.
Americans routinely take advantage of things like discount cards, coupons, financial assistance, and government programs.
However, just like anything, there are positives and negatives.
Some options can end up being limited in savings, have expensive copays or deductibles, or large gaps that mean patients lose out on getting help.
Prescription Hope offers access to affordable Alhemo and other medications for a predictable $70.00 per month, per medication. No surprises, variable pricing, or retail market fluctuations.
We are not a discount card, coupon, or insurance program. Instead, we are a comprehensive medication access service, meaning we help you access needed medications, often through patient assistance programs.
And if you don’t qualify for your intended program, we’ll work to see if another option exists, such as a substitute medication and its program, or a discount card or coupon.
In the end, if we cannot help you save, you pay nothing.
But for all who do qualify, it’s a simple, predictable, low service rate of $70.00 per month, per medication.
Ongoing Advocacy and Refill Support
Once you’ve qualified for your program and received your first shipment of medication, we continue to serve you.
Our trained advocates take care of refill scheduling, monitor your program status for any changes, update documents as needed, handle yearly renewals, and help you find solutions if your medication access changes.
Alhemo Patient Assistance Eligibility
Those wondering if they have Alhemo eligibility for the Alhemo Patient Assistance Program should know the criteria used to determine a patient’s qualification. Typically, patient assistance programs maintain requirements in several general areas. Some of those areas include:
Income threshold: Each program maintains its own income threshold for qualification purposes.
Prescription status: Every program requires a patient to have a current prescription for the medication they wish to apply for.
U.S. Residency: Every patient assistance program requires applicants to be U.S. residents.
Insurance Coverage: Each program holds unique insurance coverage requirements. Some allow for full or limited coverage, while others require lack of insurance coverage.
Simple Enrollment With Expert Support
Starting Your Journey
Those who are looking for enrollment support to get access to affordable Alhemo and hemophilia medication assistance can start their journey with Prescription Hope in 6 simple steps:
- Submit Information: Our online enrollment form only takes a few minutes to complete.
- Advocate Contact: After you complete our enrollment form, a patient advocate will contact you within 1-2 business days.
- Document Collection: Following our quick prequalification, our advocates will collect all of the required documentation for your application.
- Provider Coordination: One of our team members will connect with your healthcare provider to get the needed signatures for your application.
- Program Submission: Once everything is collected and ready, we’ll submit your application on your behalf and coordinate with the manufacturer throughout the processing stage.
- Medication Delivery: After a patient is approved, the manufacturer will ship the medication directly to their door or doorstep.
Those who wish to apply to the Alhemo Patient Assistance Program need look no further than enrolling through Prescription Hope.
Medication Delivery and Ongoing Support
After initial delivery, our advocates provide ongoing support to all of our patients. This means we handle refill scheduling, document updates, program monitoring, yearly renewals, and more.
Please note: Prescription Hope does not handle your medication. All medication shipments come directly from the manufacturer to your door or doctor’s office.
Understanding Alhemo
How Alhemo Works
People with hemophilia A or hemophilia B have low or missing clotting factors needed for normal blood clotting. Without enough clotting factor activity, the body may have difficulty forming stable blood clots, which can lead to prolonged bleeding episodes and spontaneous bleeding complications.
Alhemo works differently from traditional factor replacement therapies by targeting tissue factor pathway inhibitor, also called TFPI. TFPI is a natural protein in the body that helps slow down clotting activity. By blocking TFPI, Alhemo helps increase clotting activity even when factor VIII or factor IX levels are deficient.
This increased clotting activity may help reduce spontaneous bleeding episodes and improve overall bleed prevention in patients with hemophilia. Because the medication is designed for preventive use, ongoing treatment adherence is important to help maintain consistent bleed protection.
Alhemo is administered as a subcutaneous injection using a prefilled pen device and does not require intravenous infusion or factor replacement preparation.
What Conditions Does Alhemo Treat?
Alhemo is FDA-approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients aged 12 years and older with hemophilia A or hemophilia B, with or without clotting factor inhibitors.
Hemophilia A and hemophilia B are inherited bleeding disorders caused by deficiencies in clotting factor VIII or factor IX. Patients with these conditions may experience spontaneous bleeding episodes, prolonged bleeding after injuries, and internal bleeding involving joints, muscles, or other tissues.
Some individuals with hemophilia develop inhibitors, which are antibodies that reduce the effectiveness of traditional clotting factor replacement therapies. Alhemo may provide an additional preventive treatment option for patients both with and without inhibitors.
Because hemophilia is a lifelong condition that often requires ongoing monitoring and preventive care, many patients receive treatment through specialized hemophilia treatment centers experienced in bleeding disorder management.
Benefits of Treatment
Alhemo may help reduce the frequency of bleeding episodes and lower the risk of spontaneous bleeding in patients with hemophilia A or hemophilia B. By improving clotting activity through TFPI inhibition, the medication may support more consistent long-term bleed prevention.
Preventive treatment may help reduce bleeding-related complications, lower dependence on intravenous factor replacement therapy, and improve overall quality of life for some patients. Reducing recurrent bleeding episodes may also help decrease the risk of long-term joint damage associated with chronic bleeding into joints and muscles.
Because Alhemo is administered as a once-daily subcutaneous injection using a prefilled pen, some individuals may benefit from increased convenience compared to frequent intravenous infusions. Clinical studies demonstrated significant reductions in annualized bleeding rates compared with on-demand treatment approaches in eligible patients.
Important Safety Information and Side Effects
Alhemo may cause serious allergic or hypersensitivity reactions in some patients. Individuals should seek immediate medical attention if they experience symptoms such as severe rash, swelling, chest pain, shortness of breath, or signs of a serious allergic reaction during treatment.
The medication may also increase the risk of abnormal blood clot formation, including thromboembolic events. Patients receiving Alhemo may require ongoing monitoring of concizumab plasma concentrations and clinical response during treatment to help reduce safety risks.
Caution may be necessary when using certain bypassing agents or clotting products alongside Alhemo. Patients should discuss all current medications and hemophilia treatments with their healthcare provider before beginning therapy.
Patients should inform their healthcare provider if they have a history of blood clots, are pregnant or breastfeeding, are receiving immune tolerance induction therapy, or have other medical conditions that may affect treatment safety.
Common side effects may include:
- Injection site reactions
- Headache
- Hives (urticaria)
- Rash
- Abdominal pain
- Itching
Some patients may also experience hypersensitivity-related symptoms during treatment.
Because hemophilia treatment requires careful monitoring and individualized management, patients are often cared for through specialized hemophilia treatment centers experienced in bleeding disorder treatment. Individuals should always speak with their healthcare provider regarding the risks, benefits, and safety considerations associated with Alhemo treatment.
Access to Multiple Medications
Those who need hemophilia medication support, among other conditions, often need more than one medication to maintain a proper quality of life.
This means medication costs can skyrocket for a patient, as they attempt to pay for multiple medications out of their own pocket.
Prescription Hope’s service can help patients with multiple medications.
Even if a patient qualifies for many medications, we can help them access those medications, at a simple service rate of $70.00 per med, per month.
Why Choose Prescription Hope for Alhemo Assistance
Experienced Advocacy Support
For 20 years, we’ve helped patients across America save money on their medications every month. If a medication costs even just 5 dollars more than $70.00 per month, we may be able to help you save.
Ongoing Medication Management
We don’t just fill out your forms and collect your documents. Once you’ve received approval, we handle your refill schedule, yearly renewals, document updates, and more.
Transparent Monthly Pricing
Our service is $70.00 per month, per medication. That’s it. No surprises. And if we can’t help you, then you don’t pay.
Nationwide Medication Access Support
Since 2006, we’ve worked with a network of hundreds of pharmaceutical manufacturers and tens of thousands of healthcare providers.
So, if you’re looking for hemophilia medication assistance and don’t know where to turn, fill out our online enrollment form today, and we’ll see if we can help you save money every month on your medication costs.
